ATC Group: A07DA01 Diphenoxylate

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A07DA01 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Antidiarrheals, intestinal antiinflammatory/antiinfective agents
3
Antipropulsives
4
Antipropulsives
5
A07DA01
Diphenoxylate

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
15 mg

Active ingredients in A07DA01

Active Ingredient
Description

Diphenoxylate is a synthetic opioid derivative with selective effects on gastrointestinal smooth muscle. It is essentially devoid of “morphine type subjective effects” at therapeutic doses.

Related product monographs

Title
Information Source
Document Type
 
Health Products and Food Branch (CA)
Structured Product Monograph (SPM)

Medicines in this ATC group

United States (US)

Australia (AU)

Canada (CA)

Ecuador (EC)

Hong Kong (HK)

Poland (PL)

Singapore (SG)

South Africa (ZA)

Turkey (TR)

While we strive to include the brand names of medicines across all countries, our index remains incomplete. Therefore, it is possible that this medicine may also be marketed under different names in other countries.